Ally Bridge Group as of Dec. 31, 2023
Portfolio Holdings for Ally Bridge Group
Ally Bridge Group holds 22 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Jasper Therapeutics | 17.2 | $29M | 3.7M | 7.89 | |
| Argenx Se - Sponsored Adr (ARGX) | 7.9 | $13M | 35k | 380.43 | |
| Soleno Therapeutics (SLNO) | 7.4 | $13M | 310k | 40.25 | |
| Cymabay Therapeutics | 6.9 | $12M | 490k | 23.62 | |
| Xenon Pharmaceuticals (XENE) | 6.6 | $11M | 242k | 46.06 | |
| Intra Cellular Therapies (ITCI) | 6.0 | $10M | 141k | 71.62 | |
| Olema Pharmaceuticals (OLMA) | 5.5 | $9.2M | 659k | 14.03 | |
| Apellis Pharmaceuticals (APLS) | 5.4 | $9.0M | 150k | 59.86 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 5.2 | $8.7M | 144k | 60.39 | |
| Axsome Therapeutics (AXSM) | 4.8 | $8.0M | 101k | 79.59 | |
| Merus N V (MRUS) | 4.5 | $7.6M | 275k | 27.50 | |
| Alpine Immune Sciences | 4.1 | $6.8M | 357k | 19.06 | |
| Geron Corporation (GERN) | 3.7 | $6.3M | 3.0M | 2.11 | |
| Ambrx Biopharma | 3.3 | $5.5M | 385k | 14.24 | |
| Avadel Pharmaceuticals- Sponsored Adr | 2.9 | $4.9M | 347k | 14.12 | |
| Harpoon Therapeutics Com New | 2.9 | $4.9M | 428k | 11.37 | |
| Amylyx Pharmaceuticals (AMLX) | 2.4 | $4.1M | 276k | 14.72 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.9 | $1.6M | 70k | 22.28 | |
| Compass Therapeutics (CMPX) | 0.8 | $1.3M | 835k | 1.56 | |
| Promis Neurosciences Com New (PMN) | 0.7 | $1.2M | 1.1M | 1.15 | |
| Context Therapeutics (CNTX) | 0.5 | $820k | 726k | 1.13 | |
| Medavail Holdings Com New (MDVLQ) | 0.3 | $529k | 118k | 4.49 |
